Latest news
5 Must-Read Analyst Questions From Illumina’s Q2 Earnings Call - StockStoryStockStory · Wed, 05 Aug 2026 07:00:00 GMTWatch CNBC's full interview with Illumina CEO Jacob Thaysen - CNBCCNBC · Fri, 31 Jul 2026 07:00:00 GMTIllumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full-Year Outlook Slightly Exceeds Expectations - StockStoryStockStory · Thu, 30 Jul 2026 07:00:00 GMTStandard BioTools Sells Mass Cytometry Business and Secures $30 Million Illumina Buyout Ahead of Treeline Merger - citybizcitybiz · Tue, 28 Jul 2026 12:32:40 GMTStandard Biotools - Enters Termination, Waiver And Release Agreement With Illumina On July 24, 2026 - SEC Filing - TradingViewTradingView · Tue, 28 Jul 2026 07:00:00 GMTStandard BioTools sells Mass Cytometry business and secures $30M from Illumina earnout buyout - PluangPluang · Tue, 28 Jul 2026 07:00:00 GMT